| - Industry | - Sector | - CEO | XSHE Exchange | CNE100006VB6 ISIN |
| China Country | - Employees | 5 Jun 2026 Last Dividend | 6 Jun 2025 Last Split | - IPO Date |
Hefei Hengxin Life Science Co. Ltd. is a pioneering company focused on the development and commercialization of healthcare products in China. With a strong emphasis on the life sciences sector, the organization is dedicated to creating innovative medical devices and pharmaceutical products that enhance health and wellness. As part of a rapidly growing industry, Hefei Hengxin Life Science Co. Ltd. is committed to making significant contributions to the biotechnology and healthcare technology markets.
The company harnesses advanced research and development capabilities to address unmet medical needs and improve the quality of life for individuals worldwide. By concentrating on specialized and highly technical solutions, Hefei Hengxin Life Science Co. Ltd. assumes a vital role in advancing medical innovations and improving healthcare outcomes for various demographics. Its dedication to scientific excellence and patient care is further recognized through numerous partnerships and collaborations in the healthcare and pharmaceutical sectors.